Aplantex
Véronique Bougie holds the position of Chief Operating Officer at SemaThera Inc since July 2017, and serves as Chief Executive Officer of Anasens and Advisor at Aplantex, both roles initiated in late 2023. Bougie is also a board member for BIOQuébec and Montréal InVivo, contributing expertise to these organizations since 2020 and 2021, respectively. Previous experience includes consulting roles at Corbin Therapeutics Inc and MyX Therapeutics, alongside leadership as Chief Operating Officer and Acting Chief Executive Officer. Bougie's background in business development was honed at Gestion Univalor, where strategic project leadership was emphasized. Academic credentials include a Ph.D. candidature and a Master’s degree in Virology and Immunology, complemented by certifications in pharmaceutical product development and biopharma innovation from notable institutions such as the University of Oxford and Rutgers Business School.
This person is not in the org chart
This person is not in any offices
Aplantex
Aplantex has been created by a team of entrepreneurs and scientific specialists after a careful validation of the technical concept first formulated in 2019. With the support of their academic and industrial partners, they are now aiming at producing a large catalog of high value plant-based active ingredients to be used within the pharmaceutical, cosmetics and agri-food markets. Their proprietary technology builds on the latest scientific developments in the "omics" field, with a practical, low cost and easily scalable industrial approach. By mastering, redirecting and optimizing the metabolism of their photosynthetic phytoreplicators, they are building the industrial capacity to supply the phytochemical ingredients' market with any valuable product required by their clients.